Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women ...

Women were eligible if their bone mineral density T score at the lumbar spine, femoral neck, or total hip was lower than 0 (scores of −1 or higher typically indicate normal bone density).